Taisho Pharm <4535.T>-2008/09 group results

May 15 (Reuters) -

TAISHO PHARMACEUTICAL CO LTD

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to Six months to

Mar 31, 2009 Mar 31, 2008 Mar 31, 2010 Sep 30, 2009

LATEST YEAR-AGO COMPANY COMPANY

RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 256.21 249.66 257.00 126.00

(+2.6 pct) (+3.1 pct) (+0.3%) (-0.2%)
Operating 37.94 36.95 34.00 16.00

(+2.7 pct) (+65.3 pct) (-10.4%) (-17.9%)
Recurring 39.90 41.90 39.00 17.00

(-4.8 pct) (+68.1 pct) (-2.3%) (-18.1%)
Net 8.82 25.00 23.00 9.50

(-64.7 pct) (+62.1 pct) (+160.9%)
EPS Y30.01 Y84.01 Y79.49 Y32.83
Annual div Y27.00 Y27.00 Y27.00
-Q2 div Y12.00 Y12.00 Y12.00
-Q4 div Y15.00 Y15.00 Y15.00

NOTE - Taisho Pharmaceutical Co Ltd is a top-ranked maker of non-prescription drugs.

For latest earnings estimates made by Toyo Keizai, please
double click on 4535.TK1.